SMS Lifesciences India Limited — Results, 13-02-2025: Integrated Filing- Financial

SMS Lifesciences India Limited has announced a board meeting where it reported its financial results for the quarter and nine months ended December 31, 2024. The company recorded a revenue from operations of ₹82.88 crore, showing a year-on-year increase from ₹71.23 crore, and a net profit of ₹62.28 crore compared to ₹33.15 crore in the same period last year.

This performance reflects effective cost management and operational efficiency, enhancing financial health. Notably, the subsidiary successfully passed a USFDA inspection, positioning the group favorably for future growth. Investors may view this as a positive outlook, with prospects for continued profitability and market competitiveness.